Table A6.
Comparison of laboratory data between patients with embolic arterial occlusive AMI and non-AMI.
| Embolic Arterial Occlusive AMI (n = 61) | Non-AMI (n = 287) | p-Value | |
|---|---|---|---|
| White blood cell count, ×109/L (median, IQR) | 16.6 (11.4–19.0) (n = 59) | 12.5 (8.0–16.8) (n = 277) | <0.001 |
| CRP, mg/L (median, IQR) | 73 (19.2–174.8) (n = 52) | 44 (7.5–118.5) (n = 201) | 0.026 |
| eGFR, ml/min/1.73 m2 (median, IQR) | 56 (30–82) (n = 40) | 60 (36–85) (n = 206) | 0.41 |
| ASAT, U/L (median, IQR) | 34 (25–61) (n = 54) | 28 (19–55) (n = 187) | 0.12 |
| Amylase, U/L (median, IQR) | 69 (50–138) (n = 30) | 57 (34–122) (n = 140) | 0.15 |
| Troponin T, ng/L (median, IQR) | 39 (13–188) (n = 31) | 38 (10–183) (n = 64) | 0.82 |
| pH (median, IQR) | 7.34 (7.26–7.42) (n = 52) | 7.37 (7.27–7.42) (n = 209) | 0.92 |
| Base excess, (median, IQR) | −2.9 (−8.0–0.0) (n = 39) | −1.8 (−8.0–1.2) (n = 203) | 0.40 |
| D-dimer, mg/L (median, IQR) | 5.0 (2.0–9.5) (n = 21) | 4.5 (1.3–8.2) (n = 34) | 0.23 |
| Time point 1 *. Lactate, mmol/L (median, IQR) | 1.7 (1.3–2.3) (n = 15) | 1.7 (1.3–3.0) (n = 37) | 0.68 |
| Time point 2 **. Lactate, mmol/L (median, IQR) | 1.8 (1.3–2.9) (n = 19) | 2.2 (1.2–3.2) (n = 42) | 0.95 |
| Time point 3 ***. Lactate, mmol/L (median, IQR) | 2.4 (1.7–3.1) (n = 23) | 2.3 (1.4–3.7) (n = 75) | 0.98 |
| Time point 4 ****. Lactate, mmol/L (median, IQR) | 3.0 (1.8–5.4) (n = 54) | 2.4 (1.5–4.8) (n = 212) | 0.30 |
| Change in Lactate, mmol/L (median, IQR) between time points 4 and 1 | 0.2 (−0.1–0.8) (n = 15) | 0.50 (−0.22–2.15) (n = 34) | 0.28 |
AMI; acute mesenteric ischemia, IQR; interquartile range, CRP; c-reactive protein, ASAT; aspartate aminotransferase. * (48–72 h before diagnosis). ** (24–48 h before diagnosis). *** (12–24 h before diagnosis). **** (0–12 h before diagnosis).